Cargando…
Current situation and progress of drugs for reducing intraocular pressure
Glaucoma, the most common cause of irreversible blindness worldwide, usually causes characteristic optic nerve damage. Pathological intraocular pressure (IOP) elevation is a major risk factor. Drug reduction of IOP is the preferred treatment for clinicians because it can delay the progression of dis...
Autores principales: | Liu, Peiyu, Wang, Feifei, Song, Yuning, Wang, Menghui, Zhang, Xu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9720821/ https://www.ncbi.nlm.nih.gov/pubmed/36479139 http://dx.doi.org/10.1177/20406223221140392 |
Ejemplares similares
-
The Latest Drugs in Development That Reduce Intraocular Pressure in Ocular Hypertension and Glaucoma
por: Jayanetti, Viran, et al.
Publicado: (2020) -
Noninvasive intraocular pressure monitoring: current insights
por: De Smedt, Stefan
Publicado: (2015) -
Wearable and Implantable Intraocular Pressure Biosensors: Recent Progress and Future Prospects
por: Yang, Cheng, et al.
Publicado: (2021) -
Drug repositioning in cancer: The current situation in Japan
por: Masuda, Takaaki, et al.
Publicado: (2020) -
The Intraocular Pressure
Publicado: (1920)